This project has now ended.
Why do we need this research?
During pregnancy, small fragments of the baby’s DNA are released from the placenta into the blood. This DNA – known as cell-free fetal DNA (cffDNA) – can be picked up in the mother’s blood using a simple blood test. Tests in the second and third trimester can use the baby’s DNA to find out the sex of the baby, as well as to diagnose genetic diseases.
Recent studies have shown that women who give birth early have higher levels of cell-free DNA than women who give birth at full term. However, we don’t understand why this is the case.
What’s happening in this project?
Our researchers have performed a series of studies to investigate the link between cell-free fetal DNA and preterm birth. In particular, the team were looking at inflammation, which is how the immune system responds to unusual substances or microbes like bacteria.
Using samples of placenta donated by pregnant women after birth, they found that inflammation does not increase the amount of cffDNA. Also, using blood samples donated by pregnant women, the team found that cffDNA does not cause inflammation. Finally, our researchers found that cffDNA does not cause preterm birth in mice.
What difference will this project make?
This research has shown that cffDNA does not appear to cause inflammation or pre-term birth. It is more likely that it is premature birth that is somehow causing a rise in cffDNA. Our researchers are continuing to study the relationship between inflammation and premature birth, so that one day we might be able to stop it from happening.
Get our research updates
Tommy's funds research across the UK investigating the reasons for pregnancy complications and loss. If you're interested in being kept updated about our research and news from Tommy's, click here.
More research projects
Miscarriage and ectopic pregnancy may trigger long-term post-traumatic stress, anxiety and depression
The largest ever study into the psychological impact of miscarriage and ectopic pregnancy has shown that early-stage pregnancy loss can have a serious impact on mental health. The research was led by Professor Tom Bourne at the Tommy’s National Centre for Miscarriage Research at Imperial College London.
A pilot trial led by Tommy’s National Centre for Miscarriage Research suggests diabetes drug could be repurposed to target the lining of the womb in women with recurrent miscarriage.
More than a third of maternity doctors admitted they suffer from burnout and exhaustion. This means that they may avoid difficult cases, over-prescribe medications and care less about their patients, increasing the risk of mistakes.
Abdominal stitch is more effective than vaginal stitch for women who experience recurrent preterm births
A clinical trial has shown that an abdominal stitch can save babies’ lives by reducing preterm birth for high-risk women who have had a previous failed vaginal stitch. The trial was led and co-authored by Professor Andrew Shennan, Clinical Director of Tommy’s Preterm Surveillance Clinic.